Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes
- PMID: 37507264
- DOI: 10.1016/j.ejim.2023.07.018
Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes
Keywords: Apolipoprotein B-100; Autoantibodies; Major adverse cardiovascular events; Ox-LDL.
Conflict of interest statement
Declaration of the Competing Interest HARF received research grants of Ministry of Health of Brazil, AstraZeneca, Aché, and Pfizer; The authors declare no conflict of interest.
Comment on
-
Low Levels of Apolipoprotein B-100 Autoantibodies Are Associated With Increased Risk of Coronary Events.Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):765-71. doi: 10.1161/ATVBAHA.115.306938. Epub 2016 Feb 25. Arterioscler Thromb Vasc Biol. 2016. PMID: 26916732
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
